Page 197 - Read Online

Cristina et al. Urological application of platelet rich fibrin

Patient consent 15. Cronbach LJ. Coefficient alpha and the internal structure of tests.
Obtained from both patients. Psychometrika 1951;16:297A.
16. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson
WG; Veterans Affairs Cooperative Study Group on Transurethral
Ethics approval Resection of the Prostate. A comparison of transurethral surgery
The ethics committee of Campus Bio-Medico with watchful waiting for moderate symptoms of benign prostatic
University of Rome approved the study (REC number: hyperplasia. N Engl J Med 1995;332:75-9.
27/14 PAR) on March 2014. 17. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health
survey (SF-36). I. Conceptual framework and item selection. Med Care
1992;30:473-83.
REFERENCES 18. Apolone G, Mosconi P, Ware JE. Questionario sullo stato di salute
SF-36. Manuale d'uso e guida all'interpretazione dei risultati. Milano:
Guerini e associati; 1997.
1. Curhan GC, Speizer FE, Hunter DJ, Curchan SG, Stampfer MJ. 19. Dodd RA, Cornwell R, Holm NE, Garbarsch A, Hollingsbee DA. The
Epidemiology of interstitial cystitis: a population based study. J Urol Vivostat application system: a comparison with conventional fibrin
1999;161:549-52. sealant application systems. Technol Health Care 2002;10:401-11.
2. Teichman JM, Moldwin R. The role of the bladder surface in interstitial 20. Srikrishna S, Robinson D, Cardozo L. Validation of the Patient Global
cystitis/painful bladder syndrome. Can J Urol 2007;14:3599-607. Impression of Improvement (PGI-I) for urogenital prolapse. Int
3. Fall M, Johansson SL, Aldenborg F. Chronic interstitial cystitis: a Urogynecol J 2010;21:523-8.
heterogeneous syndrome. J Urol 1987;137:35-8. 21. Diokno AC, Homma Y, Sekiguchi Y, Suzuki Y. Interstitial cystitis,
4. American Urological Association (AUA) treatment guidelines 2011. gynecologic pelvic pain, prostatitis, and their epidemiology. Int J Urol
Available from: http://www.auanet.org/guidelines [Last accessed on 4 2003;10: S3-6.
Dec 2017] 22. Offiah I, McMahon SB, O'Reilly BA. Interstitial cystitis/bladder pain
5. Mankad PS, Codispoti M. The role of fibrin sealants in hemostasis. Am syndrome: diagnosis and management. Int Urogynecol J 2013;24:1243-
J Surg 2001;182:S21-8. 56.
6. Jackson MR. Fibrin sealants in surgical practice: an overview. Am J 23. van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K,
Surg 2001;182:S1-7. Cervigni M, Daha LK, Elneil S, Fall M, Hohlbrugger G, Irwin P,
7. Schwartz M, Madariaga J, Hirose R, Shaver TR, Sher L, Chari R, Mortensen S, van Ophoven A, Osborne JL, Peeker R, Richter B, Riedl
Colonna JO 2nd, Heaton N, Mirza D, Adams R, Rees M, Lloyd D. C, Sairanen J, Tinzl M, Wyndaele JJ. Diagnostic criteria, classification,
Comparison of a new fibrin sealant with standard topical hemostatic and nomenclature for painful bladder syndrome/interstitial cystitis: an
agents. Arch Surg 2004;139:1148-54. ESSIC proposal. Eur Urol 2008;53:60-7.
8. Fattahi T, Mohan M, Caldwell GT. Clinical applications of fibrin 24. Hunner GL. A rare type of bladder ulcer in women: report of cases.
Trans South Surg Gynecol Assoc 1914;27:247-92.
sealants. J Oral Maxillofac Surg 2004;62:218-24. 25. Johansson SL, Fall M. Clinical features and spectrum of light
9. Hong YM, Loughlin KR. The use of hemostatic agents and sealants in microscopic changes in interstitial cystitis. J Urol 1990;143:1118-24.
urology. J Urol 2006;176:2367-74. 26. Lamm DL, Gittes RF. Inflammatory carcinoma of the bladder and
10. Serrano Frago P, Allepuz Losa C, Gil Martínez P, Allué López M, interstitial cystitis. J Urol 1977;117:49-51.
Mallén Mateo E, Sancho Serrano C, Rioja Sanz LA. Treatment of 27. Tirindelli MC, Flammia G, Sergi F, Cerretti R, Cudillo L, Picardi A,
hemorrhagic cystitis secondary to cyclophosphamide. Literature review Postorino M, Annibali O, Greco R, Avvisati G, Arcese W. Fibrin glue
with regard to a case. Actas Urol Esp 2005;29:230-3. (in Spanish) for refractory hemorrhagic cystitis after unrelated marrow, cord blood,
11. O’Leary MP, Barry MJ, Fowler FJ Jr. Hard measures of subjective and haploidentical hematopoietic stem cell transplantation. Transfusion
outcomes: validating symptom indexes in urology. J Uro1 2009;49:170-5.
1992;148:1546-8, discussion 1564. 28. Cheng L, Lopez-Beltran A, Bostwick DG. Bladder pathology. In:
12. Keller ML, McCarthy DO, Neider RS. Measurement of symptoms of Interstitial cystitis. Hoboken (NJ): Wiley-Blackwell; 2012. p. 22-5.
interstitial cystitis. A pilot study. Urol Clin North Am 1994;21:67-71. 29. Lynes WL, Flynn SD, Shortliffe LD, Stamey TA. The histology of
13. Kleinbaum DG, Kupper LL, Morgenstem H. Epidemiologic Research: interstitial cystitis. Am J Surg Pathol 1990;14:969-76.
Principles and Quantitative Methods. New York: Lifetime Learning 30. Kim HJ. Update on the pathology and diagnosis of interstitial cystitis/
Publications; 1982. p. 152. bladder pain syndrome: a review. Int Neurourol J 2016;20:13-7.
14. Deyo RH, Diehr P, Patrick D. Reproducibility and responsiveness 31. American Urological Association (AUA) treatment guidelines 2016.
of health status measures. Statistics and strategies for evaluation. Available from: http://www.auanet.org/guidelines [Last accessed on 4
Controlled Clin Trials 1991;12:S142-58. Dec 2017]

190 Mini-invasive Surgery ¦ Volume 1 ¦ December 28, 2017